Almac's clinical Supply Chain Management service combines consultancy and supportive technology that helps sponsor companies
Almac’s best-in-class clinical Supply Chain Management (SCM) service combines consultancy and supportive technology that helps sponsor companies overcome technological, logistical and planning challenges increasingly experienced by biotech and pharma companies conducting global clinical trials.
As clinical studies become truly global, sponsor companies face challenges with shorter availability of complex investigational products, variable patient demands and the pressures on an increasingly stretched global supply chain. Coupled with the need for global provision of expensive comparators, sponsors are seeking oversight across all aspects of their clinical supply chain.
Almac have continued developing their unique SCM service that blends consultancy, supportive technology and end-to-end supply chain visibility. This gives sponsors more control over the complete supply chain, driving down costs, reducing timeframes and aligning clinical supply with patient demand globally.
The Almac solution of single system integration of forecasting, Material Resource Planning (MRP) and Interactive Response Technology (IRT) provides data in real-time. As a consequence, the dedicated SCM experts are able to assume responsibility to make key decisions, thereby ensuring reliable and efficient supply of clinical trial material to meet patient demand.
Almac’s latest service offering further enhances and supplements their core manufacturing, packaging and distribution services for investigational products and offers clients the best and most comprehensive clinical supply chain management solution available on the global marketplace.
Michelle Foust, Almac’s Director of Supply Chain Strategy stated “Almac has been providing clinical SCM for over 25 years and in response to the challenges experienced by our global client base, we have developed novel solutions for use across multiple study types. Indeed, we are confident that our consultancy-based offering optimizes clinical trial supply, thereby minimising waste and decreasing costs for our partners.”
Find out more about clinical Supply Chain Management – http://www.almac-scm.com
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.